Moreover, in human melanoma, infiltration of immune cells (i.e., CD8+ T cells, NK or CD4+ helper) into the tumour microenvironment is associated with improved survival and clinical response to immune therapies [30]. This evidence concerns the gene CD4 and neoplasm.